Is a complete CSE/BLAB research report available?

No complete published report is available for cse/BLAB (CSE/BLAB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

cse/BLAB stock profile: metrics, valuation and analysis

Market cap	11.5M
Revenue (ttm)	406.4K
Net income (ttm)	16.5M
EPS (ttm)	CA$0.10
Shares out	164.6M
P/E (trailing)	0.8x
Volume	2,000
Beta	-0.07

All CSE/BLAB indicators

Market & fundamental data

Available fields

175

Groups with data

Currency

CAD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees Change	0%
Employees Change Percent	0
Enterprise value	CAD -681,260
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA11042D1087
Last refreshed	2026-09-10
Market cap	CAD 11.5M
Price	CAD 0.07
Price currency	CAD
Sector	Healthcare
Sic	8734
Symbol	cse/BLAB
Website	https://britannia.life

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	143.57%
FCF yield	-3.38%
P/B ratio	0.52x
P/E ratio	0.76x
P/S ratio	28.35x
PE Ratio3 Y	2.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	22.83%
Gross Profit	CAD 92,795
Gross Profit Growth Q	-31.33%
Gross Profit Growth3 Y	-73.55%
Gross Profit Growth5 Y	-49.14%
Net Income	CAD 16.5M
Net Income Growth	122.32%
Net Income Growth Qo Q	-66.95%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Net Income Growth3 Y	120.26%
Net Income Growth5 Y	102.72%
Pretax Margin	3,806.56%
Profit Margin	4,069.61%
Profitable Quarters	CAD 3
Profitable Years	2
ROA	-5.24
Roa5y	-2
ROCE	-6.52
ROE	108.4
Roe5y	-63.09
ROIC	-20.53
Roic5y	-17.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	7.7%
EPS Growth	122.3
EPS Growth Qo Q	-66.95
EPS Growth Quarters	1
EPS Growth Years	2
EPS Growth3 Y	126
EPS Growth5 Y	82.32
Revenue Growth	6.04x
Revenue Growth Q	-40.29x
Revenue Growth Qo Q	-20.7x
Revenue Growth Years	1x
Revenue Growth3 Y	-60.99x
Revenue Growth5 Y	-34.61x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.02
Assets	CAD 24.8M
Cash	CAD 12.4M
Current Assets	CAD 14.5M
Current Liabilities	CAD 2.5M
Debt	CAD 211,517
Debt Equity	CAD 0.01
Debt FCF	CAD -0.54
Equity	CAD 22.1M
Interest Coverage	-67.07
Liabilities	CAD 2.8M
Long Term Assets	CAD 10.4M
Long Term Liabilities	CAD 246,531
Net Cash	CAD 12.2M
Net Cash By Market Cap	CAD 106
Net Cash Growth	182.78%
Net Debt Equity	CAD -0.55
Tangible Book Value	CAD 22.1M
Tangible Book Value Per Share	CAD 0.13
WACC	3.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.69
Net Working Capital	CAD -294,215
Quick ratio	5.49
Working Capital	CAD 11.9M
Working Capital Turnover	CAD 0.05

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	7.69%
200-day SMA	0.09
50-day SMA	0.07
50-day SMA vs 200-day SMA	50under200
All Time High	0.32
All Time High Change	-78.13%
All Time High Date	2021-11-18
All Time Low	0.03
All Time Low Change	133.33%
All Time Low Date	2023-12-05
ATR	0
Beta	-0.07
Beta1y	-1.8
Beta2y	-1.26
Ch YTD	-22.22
High	0.07
High52	0.14
High52 Date	2025-10-06
High52ch	-50%
Low	0.07
Low52	0.06
Low52 Date	2026-08-11
Low52ch	16.67%
Ma50ch	-4.24%
Price vs 200-day SMA	-18.89%
RSI	50.86
RSI Monthly	44.77
RSI Weekly	43.57
Sharpe ratio	0.64x
Sharpe Ratio3y	0.62x
Sortino ratio	1.1
Sortino Ratio3y	1.1
Tr YTD	-22.22
Tr1m	7.69%
Tr3m	-17.65%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	100,693,798%
Net Borrowing	-105,551
Shares Insiders	38.82%
Shares Out	164,587,579
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	82,571.35x
Bv Per Share	0.13
Ch1m	7.69
Ch1y	7.69
Ch3m	-17.65
Ch6m	-36.36
Change	0%
Change From Open	0
Close	0.07
Days Gap	0
Depreciation Amortization	62,973
Dollar Volume	140
Earnings Date	2026-11-27
EBIT	CAD -1.5M
EBITDA	CAD -1.4M
EPS	CAD 0.1
F Score	3
FCF	CAD -389,947
FCF EV Yield	57.24x
FCF Per Share	CAD -0
Financing CF	34,443
Fiscal Year End	March
Graham Number	0.55435
Graham Upside	691.9
Income Tax	CAD 507,837
Investing CF	6,037,567
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2026-06-30
Last Split Date	2021-11-18
Last Split Type	Reverse
Lynch Fair Value	CAD 2.55
Lynch Upside	3,540.7
Ma150	0.09
Ma150ch	-17.74%
Ma20	0.07
Ma20ch	3.4%
Net CF	5,698,425
Next Earnings Date	2026-11-27
Open	0.07
Ppne	65,121
Price Date	2026-09-08
Ptbv Ratio	0.52
Relative Volume	0.02x
Revenue	406,436x
Tax By Revenue	124.95x
Tax Rate	3.28%
Tr6m	-36.36%
Volume	2,000
Z Score	3.65

CSE/BLAB (CSE/BLAB)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/BLAB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/BLAB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CSE/BLAB

Frequently asked questions